Announcing the launch of the QGenome apps

There is a growing public awareness of the importance of genetic risk in the development of disease. Identifying families with inherited conditions enables access to risk-reduction measures, such as surveillance or surgery, targeted therapies, clinical trials, reproductive options and psychosocial support, leading to better patient care and outcomes. 

It is therefore important for clinicians to have readily accessible evidence-based tools to support them in recognising inherited risk, instigating genomic investigations and referring patients to specialist genomic services in a timely way. 

QGenome (formerly known as Quest Genomics) is an app-based clinical decision navigator which guides clinicians’ use of genomics, bridges the overlap between common conditions and rare diseases, and aligns with the National Genomic Test Directory and published guidance, for example NICE. 

QGenome has been designed to support all healthcare professionals working across primary, secondary and tertiary care. 

QGenome currently provides clinicians with up-to-date clinical guidance on Cancer Genomic and Familial Hypercholesterolaemia investigations and referral pathways. It will soon be expanded in Summer 2022 for use across other specialities, such as Cardiac and Renal Genomics.  

If you have any questions or queries, you are welcome to email Jessica Gutmann from SE GMSA on jessica.gutmann@gstt.nhs.uk

We can’t wait for you all to enjoy our product, and to help improve patient outcomes!  

The QGenome team, South East Genomics Medicine Services Alliance